Croda International

Croda International is a leading global specialty chemicals company that provides high-performance ingredients and technologies to some of the world's biggest brands. In the life sciences sector, the company operates as a premier supplier of high-purity excipients, vaccine adjuvants, and innovative drug delivery systems. Croda is particularly recognized for its expertise in lipid nanoparticle (LNP) technology, which is essential for the delivery of mRNA-based vaccines and therapeutics. Through its acquisition of Avanti Polar Lipids, the company has expanded its capabilities in complex lipid synthesis and formulation development for the pharmaceutical industry. Croda supports its partners from early-stage research through to commercial manufacturing, offering both catalog products and custom CDMO services.